Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's Global Phase II Clinical Trial in Treating Parkinson's Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND) application for the global multi-center phase-II clinical trial of Oligomannate...
January 17, 2022
by prnasia
KOL Views Preview: AbbVie’s ABBV-951 works but will PD patients use it?
ABBV-951 was expected to work better than oral levodopa/carbidopa and it did not disappoint in a Phase III trial for advanced Parkinson’s disease (PD).
November 1, 2021
by FirstWordPharma
Teva, Modag to develop drug candidates for neurodegenerative disease
Teva Pharmaceutical has partnered with Modag for the development and licensing of the latter’s drug candidates, anle138b and sery433, for neurodegenerative disease.
October 29, 2021
by Pharmaceutical-Business-Review
Parkinson’s disease market sales to reach $11.5 billion in 2029
The Parkinson’s disease market is set to triple in sales by 2029 driven by novel biologics and delivery systems, reports GlobalData.
August 12, 2021
by europeanpharmaceuticalreview
US grants new patent targeting major neurodegenerative diseases
Alterity Therapeutics have been granted a patent for compounds able to redistribute excess iron in the brain being developed as a treatment for neurodegenerative diseases including Alzheimer’s and Parkinson’s.
July 5, 2021
by europeanpharmaceuticalreview
Scientists at IIT Madras identify energy deficiency in brain cells as major cause for Parkinson’s Disease
The novel findings of this research may enhance understanding of the pathophysiology of Parkinson’s Disease and might finally lead to a cure.
March 11, 2021
by expresspharma
GB Sciences Announces Results from Parkinson's Disease Study
GB Sciences announced preclinical results for their Parkinson's disease (PD) formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of ...
December 23, 2019
by americanpharmaceuticalreview
Antibiotic Exposure May Be Tied to Risk for Parkinson Disease
Exposure to certain types of oral antibiotics may be associated with an elevated risk for Parkinson disease (PD), according to a study published online in Movement Disorders.
December 19, 2019
by drugs
Expansion of Peritoneal Dialysis Feasible
Expansion of the use of peritoneal dialysis (PD) is feasible, according to a study published online in JAMA Internal Medicine.
September 12, 2019
by drugs
Vitamin D Tied to Falls, Nonmotor Symptoms in Parkinson Disease
In patients with Parkinson disease (PD), vitamin D levels are significantly correlated with falls and some nonmotor symptoms, according to a study published online in Acta Neurologica Scandinavia.
August 12, 2019
by drugs
Undetected Dysglycemia Linked to MI, Periodontal Disease
Undetected Dysglycemia Linked to MI, Periodontal Disease.
June 17, 2019
by drugs
Volume Overload Present in Patients on Peritoneal Dialysis
Volume Overload Present in Patients on Peritoneal Dialysis.
May 24, 2019
by drugs